Recent Acquisitions Syngene International has recently acquired a biologics facility in the United States for $36.5 million, presenting an opportunity to expand service offerings and collaborations in the region.

Partnership Opportunities The strategic partnership between Syngene International and Orocidin A/S opens up avenues for joint projects and potential co-development initiatives, offering an opportunity for increased business growth.

Industry Recognition Syngene International's achievements in the pharmaceutical sector, such as winning the Business Expansion award and launching SynWeave protein production platform, position the company as an innovative partner for potential clients seeking cutting-edge solutions.

Employee Expertise With over 6000 scientists and dedicated research facilities for leading multinational companies, Syngene International boasts a skilled workforce capable of delivering high-quality research services, making it an attractive option for companies seeking expert scientific support.

Financial Stability Syngene International's strong financial standing, indicated by its revenue of over $1 billion and funding of $145 million, showcases reliability and financial stability to potential partners looking for long-term business collaborations.